Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Chronic Hepatitis B
Interventions
DRUG

PegIFN alfa-2b

Peginterferon alpha-2b 1.5 μg/kg per week s.c.for 48 weeks

Trial Locations (4)

200025

"Ruijin Hospital Jiaolong University", Shanghai

200083

"Public Health Center Fu Dan University", Shanghai

"Zhong Shan Hospital Fu Dan University", Shanghai

Unknown

Erasmus MC, University Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER